MIB-1 in relation to tumour response and survival in patients with breast cancer treated with primary systemic therapy
- 30 April 1999
- journal article
- Published by Elsevier in The Breast
- Vol. 8 (2) , 77-83
- https://doi.org/10.1016/s0960-9776(99)90004-8
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Primary systemic therapy for operable breast cancer - 10-year survival data after chemotherapy and hormone therapyBritish Journal of Cancer, 1997
- 13. Biological predictors of response to hormone and chemotherapyThe Breast, 1996
- Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6European Journal Of Cancer, 1994
- P-glycoprotein and resistance to tamoxifenThe Lancet, 1994
- pS2 is an independent factor of good prognosis in primary breast cancerBritish Journal of Cancer, 1993
- Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cmAnnals of Oncology, 1991
- pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine responseBritish Journal of Cancer, 1991
- Primary systemic therapy for operable breast cancerBritish Journal of Cancer, 1991
- The cytochemical detection of oestrogen receptors in fine needle aspirates of breast cancer; correlation with biochemical assay and prediction of response to endocrine therapyBritish Journal of Cancer, 1988
- HISTOLOGICAL GRADE AND RESPONSE TO ENDOCRINE THERAPY IN BREAST CANCERThe Lancet, 1981